Cristina Correia

8PUBLICATIONS
44CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Receptors and membrane biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 14, 2026
Dual FAK and EPHA2 targeting by brigatinib tackles PARP inhibitor adaptive survival response in high-grade serous ovarian cancer.

Julie R Duffield, Xiaonan Hou, Benjamin W Wilson

|Oct 16, 2025
Codon specific readthrough as a mechanism of BRCA2 restoration in acquired PARP inhibitor and chemotherapy resistance.

Cordelia D McGehee, X Wei Meng, Xinyan Wu

|Feb 14, 2025
Lysosomal NKG7 restrains mTORC1 activity to promote CD8+ T cell durability and tumor control.

Hyoungjun Ham, Jacob B Hirdler, Daniel T Bihnam

|Nov 14, 2022
A BAK subdomain that binds mitochondrial lipids selectively and releases cytochrome C.

Haiming Dai, Kevin L Peterson, Karen S Flatten

|Dec 16, 2021
NKG7 Is a T-cell-Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy.

Ti Wen, Whitney Barham, Ying Li

|Jan 08, 2021
CDK2-Mediated Upregulation of TNFα as a Mechanism of Selective Cytotoxicity in Acute Leukemia.

Husheng Ding, Nicole D Vincelette, Cordelia D McGehee

Pageof 2